ELF4 and cancer: In endometrial cancer, ELF4, acting as a transcriptional activator, is recruited to the promoter of catenin beta 1 (CTNNB1; encoding β-catenin) by tribbles pseudokinase 3 (TRIB3), thereby enhancing oncogenesis and self-renewal of cancer stem cells.115